{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:06:40Z","timestamp":1790701600853,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ahjo.2026.100888","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:46:48Z","timestamp":1788968808000},"page":"100888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effect of sodium-glucose cotransporter-2 inhibitors on electrocardiographic markers of ventricular repolarization: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"70","author":[{"given":"Muhammad Ghifari","family":"Karsa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viyola","family":"Rahma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Iqhramullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Habiburrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ahjo.2026.100888_bb0005","first-page":"e272","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ahjo.2026.100888_bb0010","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart Disease and Stroke Statistics-2023 update: a report from the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ahjo.2026.100888_bb0015","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ccep.2017.07.011","article-title":"Electrocardiographic markers of sudden cardiac death (including left ventricular hypertrophy)","volume":"9","author":"Perez-Riera","year":"2017","journal-title":"Card. Electrophysiol. Clin."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100888_bb0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.joa.2015.11.003","article-title":"Mechanisms of cardiac arrhythmias","volume":"32","author":"Tse","year":"2016","journal-title":"J Arrhythm."},{"issue":"3","key":"10.1016\/j.ahjo.2026.100888_bb0025","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jdiacomp.2016.12.001","article-title":"A large frontal QRS-T angle is a strong predictor of the long-term risk of myocardial infarction and all-cause mortality in the diabetic population","volume":"31","author":"May","year":"2017","journal-title":"J. Diabetes Complicat."},{"issue":"8","key":"10.1016\/j.ahjo.2026.100888_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136174","article-title":"Spatial\/frontal QRS-T angle predicts all-cause mortality and cardiac mortality: a meta-analysis","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ahjo.2026.100888_bb0035","first-page":"401","article-title":"Correlation of Tp-e interval and Tp-e\/Q-T ratio with malignant ventricular arrhythmia in patients with implantable cardioverter-defibrillator for primary prevention","volume":"36","author":"Zhu","year":"2016","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.ahjo.2026.100888_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.00145","article-title":"QRS-T angle predicts cardiac risk and correlates with global longitudinal strain in prevalent hemodialysis patients","volume":"10","author":"Skampardoni","year":"2019","journal-title":"Front. Physiol."},{"issue":"5","key":"10.1016\/j.ahjo.2026.100888_bb0045","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/europace\/euw280","article-title":"Traditional and novel electrocardiographic conduction and repolarization markers of sudden cardiac death","volume":"19","author":"Tse","year":"2017","journal-title":"Europace"},{"issue":"8","key":"10.1016\/j.ahjo.2026.100888_bb0050","first-page":"e382","volume":"140","author":"Kusumoto","year":"2019","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.ahjo.2026.100888_bb0055","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.ahjo.2026.100888_bb0060","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.ahjo.2026.100888_bb0065","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"36","key":"10.1016\/j.ahjo.2026.100888_bb0070","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1093\/eurheartj\/ehab560","article-title":"Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF","volume":"42","author":"Curtain","year":"2021","journal-title":"Eur. Heart J."},{"issue":"15","key":"10.1016\/j.ahjo.2026.100888_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14155306","article-title":"SGLT2 inhibitors and the risk of arrhythmias in heart failure: a network meta-analysis","volume":"14","author":"Suresh","year":"2025","journal-title":"J. Clin. Med."},{"issue":"10254","key":"10.1016\/j.ahjo.2026.100888_bb0080","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"issue":"10405","key":"10.1016\/j.ahjo.2026.100888_bb0085","doi-asserted-by":"crossref","first-page":"P883","DOI":"10.1016\/S0140-6736(23)00875-9","article-title":"The lancet commission to reduce the global burden of sudden cardiac death: a call for multidisciplinary action","volume":"402","author":"Marijon","year":"2023","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ahjo.2026.100888_bb0090","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00125-016-4134-x","article-title":"Empagliflozin decreases myocardial cytoplasmic Na(+) through inhibition of the cardiac Na(+)\/H(+) exchanger in rats and rabbits","volume":"60","author":"Baartscheer","year":"2017","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.ahjo.2026.100888_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12997\/jla.2022.11.1.1","article-title":"SGLT2 inhibitors and ketone metabolism in heart failure","volume":"11","author":"Saucedo-Orozco","year":"2022","journal-title":"J. Lipid Atheroscler."},{"issue":"10","key":"10.1016\/j.ahjo.2026.100888_bb0100","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s00125-018-4670-7","article-title":"SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review","volume":"61","author":"Verma","year":"2018","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.ahjo.2026.100888_bb0105","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat. Methods Med. Res."},{"issue":"135","key":"10.1016\/j.ahjo.2026.100888_bb0110","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"issue":"4","key":"10.1016\/j.ahjo.2026.100888_bb0115","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"issue":"7650","key":"10.1016\/j.ahjo.2026.100888_bb0120","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ahjo.2026.100888_bb0125","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae666.860","article-title":"Impact of dapagliflozin on supraventricular and ventricular arrhythmias, assessed by Holter ECG, in patients with heart failure with reduced ejection fraction","volume":"45","author":"Abdellah","year":"2024","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100888_bb0130","first-page":"49","article-title":"Comparison of the effects of SGLT2 inhibitors and sulfonylurea on electrocardiographic parameters","volume":"43","author":"Akhan","year":"2021","journal-title":"Cumhuriyet Med. J."},{"issue":"4","key":"10.1016\/j.ahjo.2026.100888_bb0135","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3390\/clinpract12040059","article-title":"Association between empagliflozin use and electrocardiographic changes","volume":"12","author":"Antwi-Amoabeng","year":"2022","journal-title":"Clin. Pract."},{"issue":"3","key":"10.1016\/j.ahjo.2026.100888_bb0140","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/pace.14463","article-title":"The effect of empagliflozin on P wave peak time and other P wave parameters in patients with diabetes mellitus","volume":"45","author":"Aslan","year":"2022","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ahjo.2026.100888_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fcdhc.2025.1537005","article-title":"Effect of dapagliflozin, a sodium-glucose co-transporter 2 inhibitor, on ventricular repolarization electrocardiographic parameters in type 2 diabetes patients: DAPA - ECG study","volume":"6","author":"Campos","year":"2025","journal-title":"Front. Clin. Diabetes Healthc."},{"issue":"6","key":"10.1016\/j.ahjo.2026.100888_bb0150","first-page":"626","article-title":"Effects of SGLT2 inhibitors as an add-on therapy to metformin on electrocardiographic indices of ventricular repolarization","volume":"36","author":"Duran","year":"2020","journal-title":"Acta Cardiol. Sin."},{"issue":"11","key":"10.1016\/j.ahjo.2026.100888_bb0155","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/jcpt.13734","article-title":"Empagliflozin has favourable effect on frontal plane QRS-T angle in diabetic patients with cardiovascular disease","volume":"47","author":"Eyuboglu","year":"2022","journal-title":"J. Clin. Pharm. Ther."},{"issue":"3","key":"10.1016\/j.ahjo.2026.100888_bb0160","doi-asserted-by":"crossref","first-page":"192","DOI":"10.47482\/acmr.1346676","article-title":"The effect of SGLT2 inhibitors on cardio-electrophysiological balance index in diabetic patients with preserved ejection heart failure","volume":"4","author":"Gokalp","year":"2023","journal-title":"Arch. Curr. Med. Res."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100888_bb0165","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4274\/kvbulten.galenos.2024.57966","article-title":"Does empagliflozin, a popular SGLT2 inhibitor, increase arrhythmia?","volume":"2","author":"Kaya","year":"2024","journal-title":"Bull. Cardiovasc. Acad."},{"issue":"7","key":"10.1016\/j.ahjo.2026.100888_bb0170","first-page":"574","article-title":"Prognostic of dapagliflozin in patient with ejection fraction preserving heart failure combined with paroxysmal atrial fibrillation","volume":"40","author":"Li","year":"2024","journal-title":"J. Clin. Cardiol. (China)"},{"issue":"2","key":"10.1016\/j.ahjo.2026.100888_bb0175","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5543\/tkda.2024.07280","article-title":"Sodium-glucose cotransporter 2 inhibitors significantly lower the cardiac electrophysiological balance index in type 2 diabetes patients","volume":"53","author":"Ozdemir","year":"2025","journal-title":"Turk Kardiyol. Dern. Ars."},{"issue":"4","key":"10.1016\/j.ahjo.2026.100888_bb0180","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.19102\/icrm.2024.15044","article-title":"Empagliflozin and dapagliflozin therapies favorably alter QRS-T angle and cardiac repolarization parameters in patients with heart failure","volume":"15","author":"Ozen","year":"2024","journal-title":"J. Innov. Card. Rhythm Manag."},{"issue":"10","key":"10.1016\/j.ahjo.2026.100888_bb0185","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/dme.13424","article-title":"Effect of sodium-glucose co-transporter-2 inhibitors on impaired ventricular repolarization in people with Type 2 diabetes","volume":"34","author":"Sato","year":"2017","journal-title":"Diabet. Med."},{"issue":"6","key":"10.1016\/j.ahjo.2026.100888_bb0190","article-title":"Effect of SGLT2 inhibitors on transmural dispersion of repolarization in ECG in patients with diabetics complicated with coronary artery disease","volume":"43","author":"Takase","year":"2022","journal-title":"Ther. Res."},{"key":"10.1016\/j.ahjo.2026.100888_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.934193","article-title":"Electrocardiographic changes associated with SGLT2 inhibitors and non-SGLT2 inhibitors: a multi-center retrospective study","volume":"9","author":"Wu","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100888_bb0200","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10557-022-07396-y","article-title":"Effect of sodium-glucose co-transporter-2 inhibitors on ventricular repolarization markers in heart failure with reduced ejection fraction","volume":"38","author":"Yilmaz","year":"2024","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"12","key":"10.1016\/j.ahjo.2026.100888_bb0205","doi-asserted-by":"crossref","first-page":"9935","DOI":"10.1007\/s00210-024-03225-1","article-title":"Evaluation of the effect of empagliflozin on prevention of atrial fibrillation after coronary artery bypass grafting: a double-blind, randomized, placebo-controlled trial","volume":"397","author":"Zarei","year":"2024","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.ahjo.2026.100888_bb0210","series-title":"The Complex Interplay Between SGLT2 Inhibitors and Atrial Fibrillation: Mechanisms and Clinical Implications","author":"Fahimi","year":"2023"},{"issue":"9","key":"10.1016\/j.ahjo.2026.100888_bb0215","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4330\/wjc.v12.i9.437","article-title":"Dispersion of ventricular repolarization: temporal and spatial","volume":"12","author":"Arteyeva","year":"2020","journal-title":"World J. Cardiol."},{"issue":"5","key":"10.1016\/j.ahjo.2026.100888_bb0220","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003607","article-title":"Repolarization heterogeneity: beyond the QT interval","volume":"5","author":"Prenner","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.ahjo.2026.100888_bb0225","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0735-1097(03)00713-7","article-title":"Ventricular repolarization components on the electrocardiogram: cellular basis and clinical significance","volume":"42","author":"Yan","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ahjo.2026.100888_bb0230","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00592-016-0864-y","article-title":"Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes","volume":"53","author":"Ninkovic","year":"2016","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.ahjo.2026.100888_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.898718","article-title":"Anti-arrhythmic effects of sodium-glucose co-transporter 2 inhibitors","volume":"13","author":"Jing","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.ahjo.2026.100888_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/jcdd9080236","article-title":"A new hope: sodium-glucose cotransporter-2 inhibition to prevent atrial fibrillation","volume":"9","author":"Karamichalakis","year":"2022","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.ahjo.2026.100888_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1011429","article-title":"Benefits of SGLT2 inhibitors in arrhythmias","volume":"9","author":"Gao","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ahjo.2026.100888_bb0250","article-title":"Antiarrhythmic effects and mechanisms of sodium-glucose cotransporter 2 inhibitors: a mini review","volume":"9","author":"Wu","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"7","key":"10.1016\/j.ahjo.2026.100888_bb0255","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.hrthm.2021.03.028","article-title":"Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: a meta-analysis of 34 randomized controlled trials","volume":"18","author":"Fernandes","year":"2021","journal-title":"Heart Rhythm."},{"issue":"6","key":"10.1016\/j.ahjo.2026.100888_bb0260","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0735-1097(00)00962-1","article-title":"Measurement, interpretation and clinical potential of QT dispersion","volume":"36","author":"Malik","year":"2000","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226001771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226001771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:35:49Z","timestamp":1790699749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666602226001771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":52,"alternative-id":["S2666602226001771"],"URL":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100888","relation":{},"ISSN":["2666-6022"],"issn-type":[{"value":"2666-6022","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of sodium-glucose cotransporter-2 inhibitors on electrocardiographic markers of ventricular repolarization: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal Plus: Cardiology Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100888"}}